Identification of synergistic drug combinations using breast cancer patient-derived xenografts. [electronic resource]
Producer: 20201116Description: 1493 p. digitalISSN:- 2045-2322
- Afatinib -- administration & dosage
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carboplatin -- administration & dosage
- Cell Line, Tumor
- Cell Survival -- drug effects
- Dose-Response Relationship, Drug
- Drug Screening Assays, Antitumor
- Drug Synergism
- ErbB Receptors -- antagonists & inhibitors
- Female
- Humans
- Imidazoles -- administration & dosage
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Naphthoquinones -- administration & dosage
- Oligopeptides -- administration & dosage
- Survivin -- antagonists & inhibitors
- Triple Negative Breast Neoplasms -- drug therapy
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.